Sanofi has taken steps to broaden its vaccine portfolio with the planned acquisition of Protein Sciences Corp of Meriden, Connecticut, US which has a protein-based influenza vaccine recently approved for the US market. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
